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The aim of this study was to check for the antibiotic susceptibility pattern and multiple antibiotic 
resistances (MAR) of extended spectrum β-lactamase (ESBL) producing Escherichia coli and Klebsiella 
species. All methods used in this study were according to the standard criteria of NCCLs. It was shown 
that there was high rate of resistance, which was alarming for health practitioners of Pakistan. 
 





Antimicrobial drugs are of two types. One is the natural 
antimicrobials which are produced by living organisms. 
Some antimicrobials are synthetic derivatives of the 
microbial substance which act as antibiotics. Cepha-
losporin and penicillin belong to such antibiotics which 
are produced by fungi. The other type is the chemical 
antimicrobials which are completely synthetic. Such type 
of antimicrobial compounds is more toxic to human cells 
when compared with the natural antibiotics. There is a 
designated concentration of each antimicrobial drug, and 
this concentration is approved by NCCLs and the health 
protection agency (NCCLs, 2005; HPA, 2006). A 
recommended concentration of the drug is not completely 
safe for humans. 
Antimicrobial drugs are classified according to their 
mechanism of action, for example, cell wall inhibiting, cell 
membrane inhibiting, protein synthesis inhibiting and 
nucleic acid inhibiting. In Microbiology diagnostic labo-
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Abbreviation: MAR, Multiple antibiotic resistance.  
step is susceptibility testing with the panel of different 
antibiotics. This panel is designed according to NCCLs 
criteria. Generally, there is Kirby-Bauer disc diffusion 
method which is used in laboratories using Muller Hinton 
media. The resistance, sensitivity and intermediate pat-
tern of antibiotics are done according to zone size which 
is mentioned in the supplement provided by NCCLs. The 
antibiotic disc is placed 30 mm away from each other. In 
this way, we can avoid synergism or antagonistic effect of 
antibiotics by mixing the antibiotics with each other 
(Cheesbrough, 2001). In this study, we analyzed the 
antibiotic resistance patterns according to the calculation 
results of multiple antibiotic resistance indices. This gives 
us an idea about the present situation of the antibiotic 
resistance in Pakistani society. 
 
 
MATERIALS AND METHODS 
 
Panel of antimicrobial drugs used 
 
The panel used in this study consists of 18 antibiotics which belong 
to three major groups of antibiotics according to the mechanism of 
action. This panel was designed according to NCCLs guidelines 
(NCCLs, 2002) and was commonly used in majority of the Pakistani 
clinical settings (Table 1). All clinical samples which came from citi 
laboratory and research, Lahore, were processed. Isolation and 
identification of strains were done  using  the   biochemical   pattern  
 




Table 1. Mechanism of action and groups of antibiotics used in the study. 
 
Mechanism of action Inhibitor of Protein synthesis  Code Concentration 
Antibiotic group Aminoglycosides   
Antibiotics Amikacin AK 30 µg 
 Gentamycin CN 10 µg 
Mechanism of action Inhibitor of  cell wall synthesis   
Antibiotic group i)Beta-lactam antibiotics Penicillin   
Antibiotics Ampicillin AMP 10 µg 
 Carbencilin CAR 100 µg 






Cephalosporin I Cephredine CE 30 µg 
Cephalosporin II Cefuroxime CXM 30 µg 
Cephalosporin III Cefoperazone CFP 75 µg 
 Ceftazidime CAZ 30 µg 
 Ceftriaxone CRO 30 µg 
 Ceftriaxone CRO 30 µg 
 Ceftizoxime ZOX 10 µg 
Antibiotic group iii)Beta-lactamase inhibitor   
 Augmentin AMC 20/10 µg 
 Tazocin TZP 100/10 µg 
Antibiotic group Monobactams   
 Aztreonam AZT 30 µg 
Antibiotic group Carbapenems   
 Imipenem IMP 10 µg 
 Meropenem MEM 10 µg 
Mechanism of action Inhibitor of  Nucleic acid   
Antibiotic group Sulfonamide    
Antibiotic Cotrimoxazole SXT 5 µg 
Antibiotic group Fluroquinolones   
 Ciprofolxacin CIP 5 µg 
 Norfloxacin NOR 10 µg 
Antibiotic group Urinary tract antiseptic   




recommended by NCCLs guidelines (NCCLs, 2002). Extended 
spectrum β-lactamase (ESBL) production was confirmed using 
health protection agency criteria via double disc synergism 
combination test and E-test (HPA, 2006). 
 
 
Multiple antibiotic resistances (MAR) calculation 
 
Multiple antibiotic resistance index (MAR) is helpful in analyzing 
health risk, and is used to check the antibiotic resistance. In this 
study, 18 antibiotics were used and are represented as (b), while 
that particular isolate is resistant to 10 antibiotics. These resistant 
antibiotics are represented as (a), then its MAR is calculated as a/b, 
which means that in this particular case, MAR is 10/18 = 0.55. 
However, if MAR is going to be calculated from such a sample site, 
where we took many isolates from, then this formula is changed. In 
such a case, we take a/(b.c) formula for calculating MAR index. 
Here, (a) represents the aggregate resistance of antibiotics to all 
isolates, while (b) represents the total number of antibiotics and (c) 
stands for the number of isolates from the specimen site. The 





In this study, the first case was used in clinical samples, 
because there was only one isolate from one site of the 
specimen which was according to our selection criteria. 
This is the general selection criteria, but when there are 
more than three antibiotics showing resistance, we can 
calculate the MAR. The value of MAR index (0.200) 










Percent frequency of MAR index (%) 
E. coli Klebsiella species 
0 7.2 11.4 
0.1 9.6 13.6 
0.2 9 11.4 
0.3 4.8 7 
0.4 13.7 9 
0.5 25 25 
0.6 12.1 7 
0.7 43.1 12 
0.8 0.8 4.5 
0.9 0 0 




between 0.200 and 0.250, it becomes a very risky phase 
where there are equal chances that MAR may fall in the 
high risk and low risk phases (Krumperman et al., 1983). 
MAR is considered as a good tool for risk assessment. 
This also gives an idea of the number of bacteria showing 
antibiotic resistance in the risk zone in the study’s routine 
susceptibility testing. This MAR index also recommended 
that all isolates, somehow, originated from the environ-
ment where antibiotics were over used (Paul et al., 1997) 
(Table 2).  
Generally, β-lactamase producing isolates showed 
resistance to the penicillin group, as well as the cepha-
losporin group. These groups are commonly used in the 
susceptibility panel, as they are widely used antimicrobial 
drugs. E. coli and Klebsiella isolates showed MAR index 
in the risk zone and they were resistance to some 
antibiotics of cephalosporin group than they were when 
they were further advanced for phenotypic detection test 
of β-lactamses (Table 2).   
 
 
Antibiotic resistance pattern of E. coli and Klebsiella 
with cell wall, protein and nucleic acid inhibiting 
drugs  
 
Antibiotic resistance pattern was studied with cell wall, 
protein and nucleic acid inhibiting drugs. β-Lactamase 
producing E. coli showed maximum resistance over 90% 
with AMP, CAR, CE, CXM, CRO and CAZ, while β-lacta-
mase producing Klebsiella showed 100% resistance with 
CAR, CE, CXM and CRO, but CAZ and AMP showed the 
resistance of both strains to be almost similar and was 
above 90%. CFP showed resistance more than 80% both 
in E. coli and Klebsiella, but in the case of AMC, the 
resistance pattern in E. coli was above 50%. However, it 
did not clearly show sensitive zones; instead intermediate 
sensitive    zones   were   more    when    compared   with 




sensitive zones. In Klebseilla, this drug had more than 
60% resistance, but here again, intermediate sensitivity 
was 20%. ZOX had above 60% resistance in E. coli, but 
above 90% in Klebsiella. MEM and IMP were considered 
as the therapy of choice, because there were very rare 
cases of MEM resistance, but no resistance was found 
with IMP in both types of strains. TZP also had good 
results with very little resistance in the case of E. coli but 
not in Klebsiella (Table 3). In the case of protein inhibiting 
drugs, CN and AK was used. CN has more than 80% 
resistance in Klebsiella but more than 60% in E. coli. On 
the other hand, AK responded well and there was very 
little resistance in E. coli, but not in Klebsiella (Table 4). 
In nucleic acid inhibiting drugs, CIP and SXT showed 
more than 80% resistance, while FN and NOR showed 
more than 90% resistance in E. coli. In Klebsiella, CIP 
had more than 70% resistance, but SXT, FN and NOR 
had resistance more than 90%. The overall resistance 
pattern presents that there is a very high resistance rate 
only for few drugs left as treatment of choice. The other 
important information which we got from these data was 
that Klebsiella had more resistance percentage than 
almost all drugs when compared with E. coli. Although, 
there was no marked difference, still some drugs seemed 
useless for β-lactamase producing Klebsiella infection 
therapy (Table 5). 
 
 
Antibiotic resistance pattern according to gender 
classification 
 
In E. coli infections, AMP, CAR, CE, CXM, CRO, CAZ, 
FN and NOR all had resistance more than 90% both in 
males and females. AMC showed nearly 70% resistance 
in both males and females. ZOX had less resistance in 
males, that is, 68% when compared with females which 
had 75% resistance. IMP and MEM had no resistance, 
while AK and TZP had resistance close to 10% in both 
genders. CN showed more resistance in males with a 
resistance of more than 65%, whereas CN resistance in 
females was 52%. However, CIP and SXT had a 
resistance of more than 85% in both genders. There were 
only two drugs, ZOX and SXT, in the case of E. coli 
infections which had different resistance patterns on the 
basis of gender group (Figure 1). In Klebsiella infections, 
AMP had more resistance in males (100%) when com-
pared with females (85%) (Figure 2). Some antimicrobial 
drugs had no difference in resistance, such as AMC and 
CN, which were above 80%, but in CAR, CE, CXM, CRO, 
FN and NOR, it was 100%. There was 100% resistance 
in males in CFP and 65% in females. In the case of CAZ 
and ZOX, there was 80% resistance in males and 100% 
resistance in females. In females, there was little 
resistance in MEM, but none in males. Moreover, there 
was no resistance in any gender with IMP, TZP and AK. 
CIP had more resistance in males  when  compared  with  
 




Table  3.  Resistance pattern of E. coli and Klebsiella species against cell wall inhibiting antibiotics. 
 
Organism 
Antibiotic resistance (%) 
AMP AMC CAR CE CFP CXM CRO CAZ ZOX IMP MEM TZP 
E. coli 95.5 53 100 96 84 94 98.8 90 63 0 0 2 
Klebsiella 90 60 100 100 80 100 100 92 90 0 10 0 
 




Table 4. Resistance pattern of E. coli and 




Antibiotic resistance (%) 
AK CN 
E. coli 4 61 
Klebsiella. 0 80 
 





females, while in SXT; there was more resistance in 
females when compared with males. Nonetheless, CFP, 
CAZ, ZOX, MEM and CIP had different resistance 
profiles on the basis of gender classification.  
 
 
Antibiotic resistance pattern according to age group 
 
Antibiotic resistance pattern was checked according to 
different age groups both in E. coli and Klebsiella β-
lacatmase infections. The age groups were prepared with 
the difference of ten years. The preparation was started 
from 0+ to 90+. In E. coli infection, AMP had a maximum 
resistance of 100% in the age group of 70+ to 90+, while 
in AMP; minimum resistance was in the age group of 0+ 
to 30+ with almost 90% resistance. In AMC, there was 
more resistance in the age group of above 70, while in 
the case of the age group from 30 to 60+, the resistance 
was almost 50%. CAR, CE, CXM, CRO, FN, NOR and 
CAZ were resistant equally, regardless of the age group. 
CFP and ZOX showed gradual increase in resistance 
with increasing age group. IMP had no resistance in any 
age group, but MEM and TZP had some resistance in the 
70+ to 90+. However, CN, CIP and SXT also had gradual 
changes in resistance with increasing age (Table 6). 
Klebsiella infection was not found in 0+, 80+ and 90+ 
age groups. In AMP, there was more than 80% 
resistance in the 10+ and 20+ age groups, while more 
than 90% resistance was found in the 30+ to 70+ age 
groups. In AMC, the age group below 30+ had less than 
60% resistance, while that above 30+ had about 65% 
resistance. CAR, CE, CXM, CRO, CAZ, FN and NOR 
had a resistance of over 90% in all  age  groups  because  
Table 5.  Resistance pattern of E. coli and 




Antibiotic resistance (%) 
CIP FN NOR SXT 
E. coli 82 96 100 85 
Klebsiella. 70 100 100 90 
 





β-lactamase had a resistance with the cephalosporin 
group. CFP had less than 80% resistance but up to 40% 
and above 80% resistance in the remaining age groups. 
IMP had no resistance but MEM, TZP and AK showed 
resistance in the 60+ and 70+ age groups. CN showed 
less than 80% resistance in the 10+, 20+ and 30+ age 
groups, but more than 80% resistance in other age 
groups. CIP had less than 70% resistance in the 10+ and 
20+ age groups, and more than 70% resistance in the 
30+, 40+ and 50+ age groups. Besides, more than 80% 
was found in the 60+ and 70+ age groups. SXT had more 
than 80% resistance in the 10+ to 50+ age groups, but 
the resistance increased to more than 90% in the 60+ 
and 70+ age groups (Table 7). The resistance pattern of 
antibiotic presented that there was gradual increase in 
the resistance with old age. Majority of the infection made 
patient at old age to be immnuo-compromised, which 
resulted in more resistance of antibiotics. β-Lactamase 
enzyme also made many drugs resistance, such as 
cephalosporin group, which was generally useful in 
routine infections. A similar case was found with the peni-
cillin group, which was the drug of choice in the routine 





Antibiotic susceptibility testing is a very important step in 
diagnostic microbiology where we can diagnose which 
therapy pattern was recommended. The importance of 
susceptibility pattern becomes more important with the 
detection of β-lactamase enzyme. This is well known that 
production  of  this  enzyme  increases  resistance  of  the  
 






Figure 1.  Antibiotic resistance in E. coli according to gender classification. See Table 1 for the full 






Figure 2. Antibiotic resistance in Klebsiella species according to gender classification. See Table 1 for the full 




antibiotic panel. The selection of E. coli and Klebsiella 
was done by performing regular ESBL phenotypic detec-
tion tests, such as Double disc synergism test, combi-
nation test and E-test. Further selection of resistance 
isolates was done according to MAR calculation, in 
places where it was checked that E. coli and Klebsiella 
had multiple antibiotic resistance index below 0.2. Then 
cephalosporin resistances were checked, before 
advancing the analyzing of antibiotic susceptibility pattern 
of β-lactamase producing isolates. The resistance pattern 
was evaluated according to gender classification and age 
group. It was shown that many antibiotics had more 
resistance in females, but some drugs were more 
resistant in males (Figures 1 and 2). The infection of E. 
coli and Klebsiella also had some antibiotic resistance 
differences. Some antimicrobial drugs had more E. coli 
resistance, while in some cases, Klebsiella showed more 
resistance patterns. There were few cases of Klebsiella 
infection, but with the increasing antibiotic resistance 
pattern. In this study, the results of amikacin, tazocin 
(Piperacillin/tazobactam), meropenem and imepenem 
was very good. A study was conducted in India, which 
showed meropenem as the best option for therapy 
against Gram negative bacilli. Although, there was high 
rate of resistance against cephalosporin drugs, the 
infection causing Gram negative bacilli was a very 
alarming condition (Goel et al., 2009). Imepenem and 
meropenem showed almost 98 to 100% sensitivity, while 
in Tazocin, 90% sensitivity was studied with different 
Gram negative bacilli which had high antibiotic resistance 
(Joly-Guillou et al., 2010). A study was conducted at King 
Fahd Hospital, Saudi Arabia, and it showed that 
meropenem was 95.8% sensitive, amikacin was 93.7% 
sensitive and imipenem was 91.7% sensitive in ESBL 
producing E. coli, while in ESBL producing Klebsiella, 
meropenem was 94.4% sensitive followed by gentamicin 
and piperacillin-tazocin which was 88.9% and amikacin 
and ciprofloxacin, which was 83.3%. The susceptibility of 
these two ESBL producer isolates were greatly reduced 
in β-lactamase inhibitor  combinations  and  trimethoprim- 
 








0+ 10+ 20+ 30+ 40+ 50+ 60+ 70+ 80+ 90+ 
AMP 90 92 90 95 94 94 95 100 100 100 
AMC 25 30 20 47 38 45 42 70 82 85 
CAR 100 99 98 100 100 100 100 100 100 100 
CE 100 90 94 100 96 100 100 98 99 100 
CFP 79 85 82 85 90 87 89 85 94 98 
CXM 95 92 96 89 90 100 100 96 97 100 
CRO 98 99 100 95 94 98 94 99 100 100 
CAZ 95 98 95 94 100 95 97 100 99 96 
ZOX 45 58 68 69 74 80 84 79 80 81 
IMP 0 0 0 0 0 0 0 0 0 0 
MEM 0 0 0 0 0 0 0 10 5 1 
TZP 0 0 0 0 1 0 0 1 4 2 
AK 0 2 0 0 0 1 4 0 0 2.5 
CN 67 55 42 68 72 75 66 69 84 70 
CIP 80 86 79 85 77 82 69 95 91 88 
FN 98 99 97 100 100 100 100 100 100 100 
NOR 100 92 100 97 100 100 100 99 99 100 
SXT 85 88 89 82 76 77 87 89 78 85 
 




sulphametoxazole (Al-Zahran and Akhtar, 2005). In this 
study’s case, the imepenem, meropenem, amikacin and 
tazocin had very good sensitivity, although, variability 
with other drugs, such as augmentin, cefoperazone, 
ceftizoxime, gentamycin and ciprofloxacin, were present.  
In another study conducted in Pakistan, the suscep-
tibility pattern of the urinary tract infection causing E. coli 
was studied. The susceptibility pattern of imepenem was 
98%, while meropenem was 97%. Gentamicin had a 
sensitivity of 48%, while ciprofloxacin was 35% and co-
trimoxazole was 17%. They also concluded that multi-
drug resistant and ESBL producing E. coli was in large 
proportion in this region (Ullah et al., 2009). The pattern 
of sensitivity was also affected with the type of infection, 
as ESBL producers had high rate of resistance to 
cephalosporin and penicillin groups when compared to 
non ESBL producers. Similarly, the rate of resistance 
increased in certain special conditions like nosocomial 
infections and in immnuo-compromised patients. Parti-
cularly, in old age, there was more resistance of drugs. In 
this study, it was found that drug resistance was high in 
the age group of above 50+, but this was not the case 
with all drugs, since majority of the drugs had no effect 
with the change in age or gender. Such drugs were 
resistance in all cases, because of β-lactamase. Some 
drugs had little variability depending on the change made 
in the age group and gender classification. A study was 
conducted in which it was discussed that with the change 
in age group, the susceptibility pattern was somewhat 
affected. Similarly, with the change in gender, there was 
effect on the susceptibility pattern, but that definitely 
depended on the site of infection. As in the urinary tract 
infections, there was more prevalence found in females. 
Similarly, more drug resistance was seen in female UTI 
cases. This study was conducted in Pakistan on diversity 
of bacterial pathogens of UTI and susceptibility pattern of 
drugs used in therapy of infections. They found that UTI 
was the leading infection in females and there was high 
resistant rate with different drugs. It was also mentioned 
that with older age, the resistance of drugs increased, 
while in young age, the resistance pattern was less 
common (Bashir et al., 2008). In another study conducted 
at Aga Khan University, Karachi presents the data which 
also support the results of this study that with the extreme 
age groups, the presence of ESBL and high drug 
resistance is more significant. They explained that these 
extreme age groups are under 5 years and above 60 
years. In ESBL producing isolates, cross resistance with 
non β-lactam drugs were also frequently seen, such as 
flouoroquinolones, aminoglycosides and co-trimoxazole 
(Jabeen et al., 2005). 
Another study was conducted at Fauji Foundation 
Hospital, Rawalpindi. The data were studied for two years 
starting from 2004 to 2006. According to the results, they 
found that ESBL was more common in females with UTI 
(64.3%). In males, the most prevalent ESBL infection site  
 









0+ 10+ 20+ 30+ 40+ 50+ 60+ 70+ 80+ 90+ 
AMP - 80 88 91 90 95 98 99 - - 
AMC - 55 57 59 60 64 65 65 - - 
CAR - 97 96 100 100 100 100 100 - - 
CE - 98 99 97 100 100 100 100 - - 
CFP - 77 75 76 78 80 84 85 - - 
CXM - 97 98 96 100 100 100 100 - - 
CRO - 97 100 98 100 100 100 100 - - 
CAZ - 94 100 95 100 100 98 95 - - 
ZOX - 87 85 92 91 95 100 100 - - 
IMP - 0 0 0 0 0 0 0 - - 
MEM - 0 0 0 0 0 5 7 - - 
TZP - 0 0 0 0 0 8 13 - - 
AK - 0 0 0 0 2 5 5 - - 
CN - 67 75 78 80 81 80 85 - - 
CIP - 65 67 70 74 71 80 84 - - 
FN - 99 98 97 100 100 100 100 - - 
NOR - 100 100 99 100 100 100 100 - - 
SXT - 80 85 87 80 84 90 92 - - 
 




was pus samples (35.7%). ESBL enteric Gram-negative 
bacilli were common in the 60+ age group, followed by 
the 40+ age group. There was less percentage of ESBL 
in the 0+ and 30+ age groups. In females, ESBL 
producers were common in middle age and later in the 
50+ age group (Mumtaz et al., 2010). These results also 
showed that UTI was the most prevalent infection 
produced by ESBL isolates in females. In males, wound 
swab/pus swab was the most prevalent site of infection 
related to ESBL producers. Similarly, more antibiotic 
resistances were common in females, but some drugs 
like SXT, CAZ and ZOX had more resistance in males in 
the case of Klebsiella infection. In E. coli infection, CAZ, 
SXT and CN had high resistance in males, while ZOX 
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